We improve lives.
Latest News
-
June 1, 2026 | News
Attacking Gout: Crystalys Sees Room for Its Dotinurad and Other Allopurinol Alternatives
-
May 26, 2026 | Press Releases
Crystalys Therapeutics Doses First Patients in New Phase 2 Trial of Dotinurad for Difficult-to-Treat Gout
-
May 6, 2026 | News
Addressing Treatment Gaps in Gout
-
April 3, 2026 | News
With A Clear Focus And Promising Asset, Crystalys Is Skipping Phase 2 Trials For Gout